Cardiac complications of checkpoint inhibitor therapy
Saturday 19 October 2019
9:30 - 10:30 CEST | 15:30 - 16:30 Beijing
Register for the live webcast
Chair
Faculty
Overview
In this multidisciplinary webcast, global experts in cardiology and oncology will discuss the practical implications of new data on the cardiotoxicity of checkpoint inhibitors, using real-world cases to illustrate clinical pearls for the cardio-oncology service.
Learning objectives
Upon completion of this activity, participants will be better able to:
- Recognise the unique cardiotoxicity profile of immune checkpoint inhibitors
- Apply evidence-based strategies to the diagnosis and management of cardiotoxicity during and after treatment with checkpoint inhibitors
Registration
To register for this webcast click here.
Target audience
This activity is primarily intended for clinicians who have special interest in the cardiovascular needs of patients with cancer, including cardiologists, oncologists, nurses, and other members of the multidisciplinary cardio-oncology team.
Financial disclosures
Shanthini Crusz
Educational Travel Grant: Tesaro.
Javid Moslehi
Consultancy: Acceleron, Ariad, BMS, Daiichi-Sankyo, Deciphera, Heat Biologics, Incyte, Ipsen, Myokardia, Novartis, Pharmacyclics, Pfizer, Regeneron, Redux Therapeutics, Rgenix, StemCentRx, Takeda/Millennium, Vertex, Verastem.
Research grants: BMS, Pfizer.
Shares: Redux Therapeutics.
Jecko Thachil
Speaker’s Bureau: Bayer, Boehringer-Ingelheim, Daichii-Sankyo, Pfizer.
Jeroen Bax and Joe-elie Salem have no relevant financial relationships to disclose.
Staff at Siyemi Learning have no relevant financial relationships to disclose.
Continuing medical education
Siyemi Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Siyemi Learning designates this live activity for 1 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
Commercial support
This activity is supported by an independent medical educational grant from Novartis.
How to earn your CME credit
At the end of the live webcast you will be required to complete a short post-test, you will then be directed to the ECOS website where you will be able to complete the evaluation and download your CME certificate.
Please contact us at cme@cme-cpd.org with any questions or concerns.
Register for the live webcast